At the 2022 edition of the Pharma Manufacturing World Summit series held March 29-30 in Boston, MA, we spoke with Daniel Dennehy of CoreRx about how pharmaceutical manufacturers are looking to enhance capacity and improve their speed in both the clinical and commercial space in a constrained business environment. From virtual and small companies all the way through to giants in the industry, every company is looking to grow and accelerate their abilities. What are some of the biggest trends and topics of conversation happening today on this important issue?

--

CoreRx is an industry leading Contract Development and Manufacturing Organization with a focus on enhanced formulations and customized development, handling and manufacturing solutions that enable our partners to meet their drug program and commercialization goals. CoreRx provides expert, added-value drug development, formulation optimization and manufacturing and packaging services for oral solid, oral liquid and semi-solid topical dosage forms. From our state-of-the-art facilities in Clearwater, Florida and San Rafael, California, we support, enhance and accelerate drug programs from clinical to commercial scale. We invite you to get to know CoreRx better and to learn how our experts can provide solutions to your most challenging drug program problems at www.corerxpharma.com.